Literature DB >> 33874649

Axial and peripheral spondyloarthritis triggered by sars-cov-2 infection: a report of two cases.

G El Hasbani1, A Jawad2, I Uthman3.   

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can show musculoskeletal symptoms such as peripheral arthritis. In rare cases, peripheral arthritis can develop after the resolution of SARS-CoV-2. We present two cases of spondyloarthritis induced by SARS-CoV-2; one case with axial and peripheral spondyloarthritis and the other with peripheral spondyloarthritis. Both cases refer to Lebanese patients who were HLA-B27 positive. These two cases highlight the possible predisposition of HLA-B27 positive patients to the development of spondyloarthritis symptoms triggered by SARS-CoV-2.

Entities:  

Year:  2021        PMID: 33874649     DOI: 10.4081/reumatismo.2021.1374

Source DB:  PubMed          Journal:  Reumatismo        ISSN: 0048-7449


  5 in total

1.  Does post-COVID reactive arthritis exist? Experience of a tertiary care centre with a review of the literature.

Authors:  Atanu Pal; Rashmi Roongta; Sumantro Mondal; Debanjali Sinha; Pradyot Sinhamahapatra; Alakendu Ghosh; Arghya Chattopadhyay
Journal:  Reumatol Clin       Date:  2022-05-12

Review 2.  Reactive arthritis occurring after COVID-19 infection: a narrative review.

Authors:  Maroua Slouma; Maissa Abbes; Takoua Mehmli; Rim Dhahri; Leila Metoui; Imen Gharsallah; Bassem Louzir
Journal:  Infection       Date:  2022-06-02       Impact factor: 7.455

3.  New-onset Polymyalgia Rheumatica Following the Administration of the Pfizer-BioNTech COVID-19 Vaccine.

Authors:  Atsumu Osada; Chinatsu Sakuragi; Chisashi Toya; Akiko Mitsuo
Journal:  Intern Med       Date:  2021-12-11       Impact factor: 1.271

4.  A Case of Axial Spondyloarthritis Triggered by SARS-CoV-2 Infection.

Authors:  Joshua Rui Yen Wong; Luke Zhu; Sachi Shah; Srinivas Gadikoppula
Journal:  Cureus       Date:  2022-03-05

Review 5.  New Onset of Autoimmune Diseases Following COVID-19 Diagnosis.

Authors:  Abraham Edgar Gracia-Ramos; Eduardo Martin-Nares; Gabriela Hernández-Molina
Journal:  Cells       Date:  2021-12-20       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.